The Division of Clinical Pharmacology offers graduate courses that take learners on a journey through the entire drug discovery and development process. These courses are taught by industry veterans and scientific experts.
Clinical pharmacology graduate courses include CLPH-D 501 (Discovering Novel Treatments) and CLPH-D 502 (Developing Clinically Approved Medicines). For details about these course offerings, interested students can email Andrew Dahlem or email Alan Palkowitz.
The Division of Clinical Pharmacology at Indiana University School of Medicine offers a doctoral minor in Therapeutic Development and Translation. This program provides future scientists and medical researchers an opportunity to jumpstart their careers through a more complete understanding of the drug discovery and development process—from bench to bedside.
The Therapeutic Development and Translation Doctoral Minor prepares students for careers in biomedical science through learning about how new medicines are discovered, developed and approved for human use.
This 12-credit program is anchored by CLPH-D 501 (Discovering Novel Treatments) and CLPH-D 502 (Developing Clinically Approved Medicines). Six other elective credits are required.
Andrew Dahlem, DVM, Chief of the Division of Clinical Pharmacology, serves as the minor advisor for the program.